Gross Margin Improvement
Gross margin in Q3 2025 was 79.9%, an 844 basis point increase compared to Q3 2024 and a 496 basis point increase compared to Q2 2025. This improvement was driven by a higher LAL mix and lower unit costs.
LAL Revenue Growth
Revenue from Light Adjustable Lenses (LAL) increased by 6% compared to Q3 2024, representing 85% of total revenue, up from 69% in Q3 2024 and 80% in Q2 2025.
Strategic Global Expansion
Successful progress in rolling out in Asia and Europe, with regulatory infrastructure and commercial initiatives supporting multiyear expansion across priority global markets.
Positive Market Reception
Strong global clinical and market enthusiasm for the Light Adjustable Lens, with increasing interest at international meetings such as the ESCRS and AAO.